Quantcast
Last updated on April 23, 2014 at 11:18 EDT

Latest Methicillin-resistant Staphylococcus aureus Stories

2014-04-16 23:06:57

Officials at Clearstream, LLC, who previously spoke out about MRSA’s prevalence in athletic facilities, are now warning of the infection’s spread to communities. In order to prevent what is now a growing public health threat, Clearstream is advancing the first antimicrobial technology that actively provides long-term protection without the use of harmful poisons. Harrisburg, NC (PRWEB) April 16, 2014 Historically, MRSA infections were relegated to sick patients in hospitals and...

2014-04-15 14:47:01

Penicillin, one of the scientific marvels of the 20th century, is currently losing a lot of battles it once won against bacterial infections. But scientists at the University of South Carolina have just reported a new approach to restoring its combat effectiveness, even against so-called “superbugs.” Bacteria have been chipping away at the power of the penicillin family of drugs since their first wide-scale use as antibiotics in the 1940s. For example, the staph infection, brought...

MRSA in petri dish
2014-04-10 08:11:45

April Flowers for redOrbit.com - Your Universe Online A new technique to predict the toxicity of a MRSA (methicillin-resistant Staphylococcus aureus) infection from its DNA sequence has been developed by a team of researchers led by the Universities of Bath and Exeter. MRSA remains a public health concern among doctors who are trying to find appropriate treatment options. It and other bacterial pathogens are able to cause disease partially because of toxicity, which is the bacterium's...

2014-04-08 12:31:11

WOBURN, Mass. and VEDBAEK, Denmark, April 8, 2014 /PRNewswire/ -- AdvanDx, Inc. today announced it has closed a $12 million financing led by Merck Global Health Innovation Fund (Merck GHI) with participation from existing investors SLS Ventures AB and LD Pensions. The Series B-1 financing will be used to fund the expansion of AdvanDx's molecular diagnostic product offerings, as well as its sales and marketing presence in the U.S. and internationally. "We continue to see increased...

2014-04-08 08:30:41

Vestagen educational campaign advocates for healthcare workers to "Keep the Coat" as an important first line of defense against contaminants ORLANDO, Fla., April 8, 2014 /PRNewswire/ -- To draw attention to the role healthcare worker attire can play in transmitting pathogens, Vestagen Technical Textiles, Inc. today launched a "Keep the Coat" awareness campaign. The effort intends to bring understanding that, with new technological advancements, what care providers wear can actually...

2014-04-08 08:29:54

IRVINE, Calif., April 8, 2014 /PRNewswire/ -- Sideromics LLC, a pharmaceutical company specializing in the development of novel antimicrobial compounds, announced today that the company has successfully completed a Type B pre-investigational new drug (PIND) meeting with the U.S. Food and Drug Administration (FDA) Division of Anti-Infective Products (DAIP). The purpose of the meeting was to obtain FDA concurrence on the nonclinical, clinical, and regulatory pathway for the development of...

2014-04-08 08:26:38

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/mt7l8d/antibiotic ) has announced the addition of the "Antibiotic Resistance: Market Developments, Growth Areas and Opportunities 2014" [http://www.researchandmarkets.com/research/mt7l8d/antibiotic ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Threats posed by the global increase in antibiotic resistant bacterial...

2014-04-03 12:27:08

Lipoglycopeptides Dalvance and Oritavancin Will Find Favorable Uptake as Convenient Outpatient Anti-MRSA Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., April 3, 2014 /PRNewswire/ -- Decision Resources Group finds that following its launch, Cubist's second generation oxazolidinone Sivextro will be highly differentiated from other anti-MRSA (methicillin-resistant Staphylococcus aureus) agents for the treatment of complicated skin and skin structure infections...

2014-04-01 08:29:55

CHICAGO, April 1, 2014 /PRNewswire-USNewswire/ -- "Get tested", says MRSA Survivors Network's founder and national spokesperson Jeanine Thomas. "It could save your life". Healthcare-acquired infections, community-acquired MRSA methicillin-resistant staphyloccocus aureus (CA-MRSA) and antimicrobial resistance- (AMR) are a major global health threat and crisis. Every single day in the United States >200 patients die from a preventable healthcare-acquired infection. Patients...

Clostridium difficile
2014-03-27 05:21:42

redOrbit Staff & Wire Reports - Your Universe Online About one of 25 men and women receiving medical care in American hospitals on any given day will acquire an infection during the course of their treatment, according to new estimates released Wednesday by the US Centers for Disease Control and Prevention (CDC). According to Kim Painter of USA Today, the federal health agency report said that even though these incidents are preventable, they affect 648,000 patients per year....